Patent · US Active

Antibody-drug conjugates

US8586049B2 · kind B2 · utility

38Cited by
9References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2012
Grant dateNov 19, 2013
Priority date—
Expiry dateSep 14, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are anti-5T4 antibody drug conjugates and methods for preparing and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.